Arbutus Biopharma (ABUS) Operating Margin Growth (3y) (2016 - 2026)
Arbutus Biopharma (ABUS) Operating Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | 35,470.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,470.00 |
| Dec 31, 2025 | -14,205.00 |
| Sep 30, 2025 | -133,762.00 |
| Jun 30, 2025 | 11,293.00 |
| Mar 31, 2025 | -136,963.00 |
| Dec 31, 2024 | -23,654.00 |
| Sep 30, 2024 | -105,006.00 |
| Jun 30, 2024 | -45,003.00 |
| Mar 31, 2024 | -52,202.00 |
| Dec 31, 2023 | -28,403.00 |
| Sep 30, 2023 | 53,633.00 |
| Jun 30, 2023 | 47,267.00 |
| Mar 31, 2023 | 62,136.00 |
| Dec 31, 2022 | 44,756.00 |
| Sep 30, 2022 | 267,446.00 |
| Jun 30, 2022 | 306,249.00 |
| Mar 31, 2022 | 273,987.00 |
| Dec 31, 2021 | 35,867.00 |
| Sep 30, 2021 | 149,209.00 |
| Jun 30, 2021 | 97,176.00 |